-
1
-
-
0036210918
-
-
Jones MB, Krutzsch H, Shu H, Zhao Y, Liotta LA, Kohn EC, Petricoin EF 3rd. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer. Proteomics 2(1):76-84, 2002.
-
Jones MB, Krutzsch H, Shu H, Zhao Y, Liotta LA, Kohn EC, Petricoin EF 3rd. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer. Proteomics 2(1):76-84, 2002.
-
-
-
-
2
-
-
0035060005
-
Correlation of in vitro cytotoxicity and clinical response to chemotherapy in ovarian and breast cancer patients
-
Agiostratidou G, Sgouros I, Galani E, Voulgari A, Chondrogianni N, Samantas E, Dimopoulos MA, Skarlos D, Gonos ES. Correlation of in vitro cytotoxicity and clinical response to chemotherapy in ovarian and breast cancer patients. Anticancer Research 21(1A):455-9, 2001.
-
(2001)
Anticancer Research 21(1A)
, pp. 455-459
-
-
Agiostratidou, G.1
Sgouros, I.2
Galani, E.3
Voulgari, A.4
Chondrogianni, N.5
Samantas, E.6
Dimopoulos, M.A.7
Skarlos, D.8
Gonos, E.S.9
-
3
-
-
0030575911
-
Laser capture microdissection
-
Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA, Liotta LA. Laser capture microdissection. Science 274(5289): 998-1001, 1996.
-
(1996)
Science
, vol.274
, Issue.5289
, pp. 998-1001
-
-
Emmert-Buck, M.R.1
Bonner, R.F.2
Smith, P.D.3
Chuaqui, R.F.4
Zhuang, Z.5
Goldstein, S.R.6
Weiss, R.A.7
Liotta, L.A.8
-
4
-
-
0035872483
-
Whole genome amplification and high-throughput allelotyping identified five distinct deletion regions on chromosomes 5 and 6 in microdissected early-stage ovarian tumors
-
Wang VW, Bell DA, Berkowitz RS, Mok SC. Whole genome amplification and high-throughput allelotyping identified five distinct deletion regions on chromosomes 5 and 6 in microdissected early-stage ovarian tumors. Cancer Research 61(10):4169-74, 2001.
-
(2001)
Cancer Research
, vol.61
, Issue.10
, pp. 4169-4174
-
-
Wang, V.W.1
Bell, D.A.2
Berkowitz, R.S.3
Mok, S.C.4
-
5
-
-
0037260139
-
Cancer statistics, 2003
-
Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
-
(2003)
CA Cancer J Clin
, vol.53
, pp. 5-26
-
-
Jemal, A.1
Murray, T.2
Samuels, A.3
Ghafoor, A.4
Ward, E.5
Thun, M.J.6
-
6
-
-
0003415798
-
-
4th ed
-
Hoskins WJ, Perez CA, Young RC, Barakat RR, Markman M, Randall ME. Principles and Practice of Gynecologic Oncology. 4th ed. 2005.
-
(2005)
Principles and Practice of Gynecologic Oncology
-
-
Hoskins, W.J.1
Perez, C.A.2
Young, R.C.3
Barakat, R.R.4
Markman, M.5
Randall, M.E.6
-
7
-
-
19944430097
-
Resistance of ovarian carcinoma cells to docetaxel is XIAP dependent and reversible by phenoxodiol
-
Sapi E, Alvero AB, Chen W, O'Malley D, Hao XY, Dwipoyono B, Garg M, Kamsteeg M, Rutherford T, Mor G. Resistance of ovarian carcinoma cells to docetaxel is XIAP dependent and reversible by phenoxodiol. Oncology Research 14(11-12):567-78, 2004.
-
(2004)
Oncology Research
, vol.14
, Issue.11-12
, pp. 567-578
-
-
Sapi, E.1
Alvero, A.B.2
Chen, W.3
O'Malley, D.4
Hao, X.Y.5
Dwipoyono, B.6
Garg, M.7
Kamsteeg, M.8
Rutherford, T.9
Mor, G.10
-
8
-
-
0043279987
-
Epithelial ovarian cancer cells secrete functional Fas ligand
-
Abrahams VM, Straszewski SL, Kamsteeg M, Hanczaruk B, Schwartz PE, Rutherford TJ, Mor G. Epithelial ovarian cancer cells secrete functional Fas ligand. Cancer Research 63(17):5573-81, 2003.
-
(2003)
Cancer Research
, vol.63
, Issue.17
, pp. 5573-5581
-
-
Abrahams, V.M.1
Straszewski, S.L.2
Kamsteeg, M.3
Hanczaruk, B.4
Schwartz, P.E.5
Rutherford, T.J.6
Mor, G.7
-
9
-
-
0041411313
-
The Fas/Fas ligand system and cancer: Immune privilege and apoptosis
-
Abrahams VM, Kamsteeg M, Mor G. The Fas/Fas ligand system and cancer: immune privilege and apoptosis. Molecular Biotechnology 25(1): 19-30, 2003.
-
(2003)
Molecular Biotechnology
, vol.25
, Issue.1
, pp. 19-30
-
-
Abrahams, V.M.1
Kamsteeg, M.2
Mor, G.3
-
10
-
-
0030671396
-
Genetic structure and chromosomal mapping of MyD88
-
Hardiman G, Jenkins NA, Copeland NG, Gilbert DJ, Garcia DK, Naylor SL, Kastelein RA, Bazan JF. Genetic structure and chromosomal mapping of MyD88. Genomics 45(2):332-9, 1997.
-
(1997)
Genomics
, vol.45
, Issue.2
, pp. 332-339
-
-
Hardiman, G.1
Jenkins, N.A.2
Copeland, N.G.3
Gilbert, D.J.4
Garcia, D.K.5
Naylor, S.L.6
Kastelein, R.A.7
Bazan, J.F.8
-
11
-
-
9144255378
-
Adjuvantmediated tumor regression and tumor-specific cytotoxic response are impaired in MyD88-deficient mice
-
Akazawa T, Masuda H, Saeki Y, Matsumoto M, Takeda K, Tsujimura K, Kuzushima K, Takahashi T, Azuma I, Akira S, Toyoshima K, Seya T. Adjuvantmediated tumor regression and tumor-specific cytotoxic response are impaired in MyD88-deficient mice. Cancer Research 64(2):757-64, 2004.
-
(2004)
Cancer Research
, vol.64
, Issue.2
, pp. 757-764
-
-
Akazawa, T.1
Masuda, H.2
Saeki, Y.3
Matsumoto, M.4
Takeda, K.5
Tsujimura, K.6
Kuzushima, K.7
Takahashi, T.8
Azuma, I.9
Akira, S.10
Toyoshima, K.11
Seya, T.12
-
12
-
-
18944403329
-
Cross talk between MyD88 and focal adhesion kinase pathways
-
Zeisel MB, Druet VA, Sibilia J, Klein JP, Quesniaux V, Wachsmann D. Cross talk between MyD88 and focal adhesion kinase pathways. Journal of Immunology 174(11):7393-7, 2005.
-
(2005)
Journal of Immunology
, vol.174
, Issue.11
, pp. 7393-7397
-
-
Zeisel, M.B.1
Druet, V.A.2
Sibilia, J.3
Klein, J.P.4
Quesniaux, V.5
Wachsmann, D.6
|